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ABSTRACT 
The metabolism of the fa t ty  acid moieties 
of brain cerebrosides, sulfatides, and 
gangliosides is reviewed and discussed. 
The methodology involved in the isolation 
of the fa t ty  acids is described briefly. I t  
seems clear now that most of these acids 
are made by chain elongation of inter- 
mediate length fa t ty  acids by addition of 
acetate residues. The unsaturated acids 
are made by desaturation of the inter- 
mediate length acids (palmitic, heptade- 
canoic, stearic) followed by chain elonga- 
tion. The hydroxy acids are made directly 
from the corresponding nonhydroxy acids, 
saturated, unsaturated, and odd-numbered. 
All the hydroxy acids undergo oxidative 
decarboxylation to yield fa t ty  acids con- 
taining one less carbon atom. The odd- 
numbered acids are also made from 
propionate, which is elongated to inter- 
mediate length acids and then to longer 
acids. The major  intermediate length 
"primer" acid seems to be palmitate, but 
there is evidence that the stearate used 
for cerebroside synthesis is also made 
d e  n o v o  from acetate. The ganglioside 
fa t ty  acids were found to turn over some- 
what faster than the other fa t ty  acids. Two 
metabolic pools for the cerebroside acids 
were found, one with a very high turnover 




I~E BtCAII~ GLYCOLIPIDS covered in this 
paper  are the cerebrosides, sulfatides, and 
gangliosides. More specifically, these are 
ceramide galaetoside, cerebroside sulfate (sul- 
furic acid ester of eerebrosides, attached to 
the 3-position of the galactose), and the ce- 
ramide polysaccharides containing neuraminic 
acid. These lipids occur as families, differing 
within each family as to the nature of the fa t ty  
acid in the ceramide residue. The cerebrosides 
1 Presented at the Prof. :Ernst Klenk Symposium o n  
Glycolipids and the Nervous System, AOCS meeting, 
Houston, April 1965. 
2 Abbreviations: RCA, relative ca rboxy l  a c t i v i t y  
(activity in COOH g r o u p X  1 0 0 / a c t i v i t y  in  to t a l  
F A ) ;  FA, fatty acid, HFA, 2-hydroxy fatty acid; NFA, 
nonhydroxy fatty acid; 18:0, s.tearic acid; 18:1, oleic 
acid; 16:19, palmitoleic acid as is 16:1s7.  An h 
symbolizes a 2-hydroxy l~A, thus h24:0 is c e r e b r o n i e  
acid (2-hydroxy]ignoceric acid). A k indicates a 2-keto 
FA. C is chloroform; E, ether; H, hexane; 1~, methanol. 
and sulfatides contain N F A  and t I F A ,  
saturated and unsaturated;  the gangliosides, 
however, contain only N F A  in which there are 
only traces of unsaturated acids. In  the cere- 
t)rosides and sulfatides there are two clusters 
of F A :  those around 18 carbons long and those 
around 24 carbons long. In  the gangliosides 
there is only one cluster, centering around 18:0, 
with negligible amounts of 22:0 and 24:0. 
Other points of contrast between gangliosides 
and the other two can be made:  the former 
occurs pr imari ly  in brain gray matter, the 
latter are pr imari ly  in white. The former 
has glucose attached to the ceramide residue, 
the latter have galactose. The former has 
only traces of odd-numbered F A ;  the latter 
can contain considerable amounts of C~ and 
C2.~ FA.  Fur ther  differences, part icularly in 
the metabolism of the two groups of glyeo- 
lipids, will be described below. 
This paper  describes mainly the studies 
carried out in this laboratory, generally with 
live rats. I t  discusses the special problems of 
isolation that  were encountered, as well as the 
interpretation of the isotopic data that were 
obtained. I t  is hoped that the approaches used 
will be of value in other types of studies. 
SPECIAL PROBLEMS OF ISOLATION 
Technical problems made this s t u d y  partic- 
ularly difficult. These arose from several 
factors : 
(a) Judging by experiments with adult ani- 
mals the blood-brain barrier  causes the brain 
to come out second-best when there is a com- 
petition for intraperitoneally administered 
isotopic precursors. The liver and other organs 
pick up most of the injected material, so that  
large amounts of radioactivity must be ad- 
nfinistered to each animal in order to get useful 
levels of incorporation into the brain. While 
intraeranial  injection yields much better utili- 
zation of labeled material, it  does not seem to 
be reproducible or physiological enough to 
warrant  use in turnover and other quantitative 
studies. Because of the blood-brain barrier  and 
the relatively leisurely rate of metabolism in 
the brain, the glycolipid F A  obtained from 
labeled acetate administration have low specific 
activities. This prevents use of the convenient 
GLC-ionization chamber combinations, which 
allow rapid  determination of the radioactivity in 
each FA.  
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(b) I f  the individual F A  in each glyeolipid 
family is to be quantified and its relative radio- 
activity is to be measured, the glyeolipid fam- 
ily must be isolated from the brain in nearly 
]00% yield. Methods which involve losses in- 
evitably give unequal losses of the various 
individual members. 
(e) Because of the high amounts of odd F A  
in many glyeolipid samples, GLC separations 
of the highest quality are needed. 
(d) Since GLC methods, on a preparat ive 
scale at least, do not give complete separation 
of saturated from unsaturated FA,  and N F A  
from H F A ,  it is necessary to carry out pre- 
l iminary class separations. 
(e) The methyl esters of the 2-hydroxy F A  
do not, in our hands, undergo GLC separation 
without destruction. I t  is therefore necessary 
to protect the OH group prior  to GLC. In  
experiments where the isolated H F A  is to be 
degraded chemically, it  is necessary to use an 
easily removed protecting group. 
(f) Because of the great length of the 
glyeolipid F A  (up to C~), part icular ly strin- 
gent requirements are placed on the techniques 
for  GLC. "Bleed" materials from packings 
contaminate the GLC effluents. 
This list of difficulties is offered to enlist 
not only the reader's sympathy but also his 
skepticism toward studies in which the im- 
portance of the factors was inadequately 
appreciated. 
SPECIt~IC METHODS OF ISOLATION 
Ganglioside l~atty Acids 
As in most of the recent methods for  ganglio- 
side isolation or analysis, we ~se a version of 
the later extraction-parti t ioning system of 
Foleh, Lees, and Sloane Stanley (8,26,17). The 
upper  layer of this solvent system contains 
nearly all the gangliosides, as well as an un- 
known lipid in which the I~A are ester-linked. 
Isolation procedures which rely on dialysis 
as the pr imary  purification step (following 
parti t ion) cannot eliminate this impurity. The 
ester-linked F A  account for  nearly all the 
]8:1  in such extracts. 
For  simple analytical work, we renmve most 
of the esterified F A  by a back-extraction with 
"Foleh lower phase" (8), but for isotopic 
work we saponify the ganglioside extract with 
mild aqueous alkali, extract the free FA,  and 
then process the purified gangliosides. The F A  
are obtained by evaporating the solution to 
dryness, methanolyzing with HCI-IV[, and ex- 
tracting with hexane. We have made the 
methanolysis step convenient and reliable by 
using a test tube with an O-ring closure (25). 
Cerebrosides and Sulfatides 
In  our earlier work (36,18) we used Florisi l  
to remove nonpolar lipids (mainly cholesterol), 
gangliosides, and nearly all the phosphatides 
from the total brain lipids. The potentialities 
of this interesting and economical adsorbent 
were thus brought to the attention of workers 
in the field of the complex lipids. Following 
the suggestion of Carroll ( 5 )  we have more 
recently been using Florisi l  deactivated by 
addition of water. We first dry the powder 
thoroughly by heating at 600C for 60 min, 
then add 8 nfl water per  100 g powder. The 
separating power of such Florisil  undergoes a 
rather sudden deterioration after 3 months, 
and we discard the outdated material. I t  is 
likely that cold storage of the wetted material 
would prolong its life. Perhap~ the adsor- 
bent, which is copreeipitated silica gel and 
magnesia, slowly reacts in the presence of 
water to form magnesium silicate. 
Sulfatides are not readily separated from 
eerebrosides by Florisil,  so we used synthetic 
ion exchange resins to isolate the sulfatides 
from the mixture (37). Impurit ies in the 
resins, as well as other exchangers we tried, 
kept us from prepar ing pure sulfatides by this 
approach. As Rouser and his co-workers have 
shown (39), it is possible to make ion exchange 
practical by purifying the ion exchanger and 
eluting reagent very extensively. 
Our previous methods called for the use o f  
large Florisi l  eolunms since much o~ the total 
brain lipids had to be retained by the adsor- 
bent. We now carry out a preliminary cleavage 
of the ester-linked lipids, following removal of 
gangliosides by solvent part i t ioning (17). The 
lipids are stirred 1 hr at room temperature in 
0.07 N NaOH in C-M 2:1, then parti t ioned 
with aqueous acetic acid to remove glyeero- 
phosphate esters. This treatment converts the 
ester-linked F A  and par t  of the free F A  (7) 
to methyl esters, which are then readily isolated 
by Florisil  chromatography. The same column 
also yields brain, cholesterol quantitatively. 
Cerebrosides and sulfatides are eluted with 
C-M 3:1. Because of the pr ior  methanolysis 
step, the Florisil  column has to adsorb just 
the cholesterol, cerebrosides, sulfatides, and 
lyso derivatives of the alkenyl and alkyl phos- 
phatides. I f  the cholesterol is not wanted, it  
can be eluted with the methyl esters, thereby 
reducing the size of the column further. 
This procedure is of additional interest as 
it yields the ester-linked F A  in the form of 
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methyl esters, ready for GLC, by a very mild 
and rapid process. There is no contamination 
by acetals or aldehydes since the lysophos- 
phatidal derivatives formed during trans- 
esterification are held back by the Florisil. 
Most of the free FA are also held by the 
Florisil under these conditions. 
The availability of a superior quality of 
silica gel (Unisil, Clarkson Chemical Co.) has 
made it possible to get good separation of 
the two glycolipids obtained from Florisil 
columns (17). The mixture is applied to the 
Unisil column in C-M 98:2, and eluted further 
with this solvent to remove eeramide. Elation 
with C-M 94:6 gives the eerebrosides, and C-M 
85:15 gives the sulfatides, slightly contaminated 
with cerebroside. This method is the simplest 
one available. 
Isolation and Analysis of Cerebroside r a t t y  
Acids 
The methyl esters of the NFA and I-IFA 
can be separated readily with l~lorisil eolulnns 
(18,20). The unsaturated and saturated esters 
in each group can be separated with Florisil 
by first forming the methoxy mercuriacetate 
derivative of the former esters. The mercury 
derivative is sufficiently polar that it sticks 
firmly to Florisil. The saturated esters are 
eluted with hexane or H-E, and the mercury 
derivative is eluted with chloroform-alcohol- 
HCI. The IICl regenerates the original un- 
saturated ester during elution. Now that good 
silica gel is available the above separations can 
be performed equally well with that adsorbent; 
however, Florisil is somewhat cheaper. 
In  the course of various problems we have 
also isolated the hydroxy acids as the copper 
chelate (20), and have separated the saturated 
from unsaturated FA esters with silver nitrate- 
silica gel columns (21). The OH group does 
not interfere in the latter method, but there is 
appreciable overlap in the elution of un- 
saturated NFA and saturated t tFA.  
The H F A  methyl esters can under some 
conditions apparently be isolated by GLC 
without derivatizing the OH group (34). How- 
ever, we found it necessary to form the methyl 
ethers (18) or acetate esters (11,20). The 
acetate esters are more convenient to make and 
are necessary when subsequent degradations 
are to be performed, but the methyl ethers 
separate more sharply and at lower tempera- 
tures in GLC. 
Application of these techniques led initially 
to the discovery that the NFA and H F A  in 
rat and human cerebrosides greatly resemble 
one another in chain length distribution, ex- 
cept for the relative absence of h18:0 (18,35). 
The saturated FA of both types differ in 
distribution from the unsaturated FA. On 
this basis we suggested that tile NFA are made 
from the I t F A  or vice versa. A second major 
finding was the high concentrations of the C~, 
and C.~ FA, the relative amounts increasing 
with age remarkably (19). As is now known, 
this is the result of conversion of the C~, and Cs~ 
acids to the odd-numbered FA by a 1-carbon 
degradation system. 
CHAIN ELONGATION vs DE NOVO 
SYNTHESIS OF THE GLYCOLIPID 
FATTY ACIDS 
Interpretation of Isotopic Data 
I t  is now well established by in vitro work 
that there are two main pathways of biosyn- 
thesis of NFA. One is the de novo route, the 
other is chain elongation of intermediate length 
FA (13,15). The former system has been pre- 
pared in soluble form from various organisms 
and tissues, including brain (2). This system 
is able to synthesize 16:0 from aeetyl CoA, via 
malonyl CoA, in one fell swoop without ap- 
preciable dilution by adjacent short-chain FA 
molecules. (The intermediate formation of 
malonate, ineidentaIIy, was first proposed to a 
scientific gathering at a Gordon Research Con- 
ference in 1958 by the senior author.) There 
is evidence that 14:0 is also formed by the 
soluble system, but it is not yet clear whether 
any 18:0 is formed in this way. 
An enzyme system which elongates FA is 
found in mitochondria and acts by adding C~ 
units (acetyl CoA or malonyl CoA) to medium 
length acids, sueh as 16:0 or 16:1. Mierosomes 
are known to synthesize FA but the mechanism 
is not yet known. Since somewhat more fornm- 
tion of 18:0 than 16:0 is observed in mi- 
erosomes (28), one might expect that both 
systems are present. However, on the basis 
of findings described below, we suggest that 
the microsomes make both acids by the de novo 
route. 
A way of determining which route is 
operating in a live animal is to administer 
COOH-labeled aeetate, isolate the FA of in- 
terest, and deearboxylate it. I f  the FA is 
made only by the de novo system, the radio- 
activity in each odd carbon atom should be the 
same, regardless of the time at which the 
animal is sacrificed. Thus the activity in tile 
FA's  earboxyl carbon should be 1/s the total 
activity in the case of 16:0, 1/9 the total in 
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18:0, etc. On a percentage basis, the RCA 
for 16:0 should be 12.5%. 
I f  a FA is made by chain elongation, the 
RCA can be greater than, equal to, or less than 
the de novo value, depending on when the 
animal is killed after the isotope has been 
administered. This can be seen by considering 
the relative activities in the acetate and palmi- 
tare pools. Shortly after injection of acetate- 
1-C ~', the brain acetate pool becomes highly 
radioactive. The 16:0 pool in brain is assumed 
to consist of free pahuitic acid, previously 
formed by synthesis from cold acetate as well 
as breakdown of complex lipids. Each non- 
radioactive 16:0 molecule condenses with a 
labeled acetate residue, forming 18:0 in which 
all of the C ~' is in the COOH group (RCA 
100%). As time passes, the 16:0 pool becomes 
highly radioactive and the acetate pool loses 
much of its activity due to the rapid metabolism 
characteristic of this intermediate. Thus 18:0 
molecules made later will contain rather little 
activity in their COOH groups, the RCA thus 
falling below the de novo value. 
Samples of 18:0 isolated at various time 
intervals will exhibit a wide range of RCA's, 
depending on the relative turnover rates of 
acetate, 16:0, and 18:0. At all times the 
isolated 18:0 will consist of a mixture of 
molecules formed at different times and with 
differing RCA's. I f  one were to carry out 
such a study with only a single time point, 
one might accidentally find an RCA characteris- 
tic of the de novo value. 
As was indicated above, it is conceivable 
that the acetate pool might be used to form 
16:0 de novo and then, without delay, used to 
elongate the 16:0 molecules. In  this case it 
would appear that 18:0 was made de novo. 
However, it is known that free FA, including 
]6:0, occur in brain (7,40) and that many of 
the complex lipid molecules of brain undergo 
hydrolytic release of their FA moieties, pre- 
At first: 
c---------n 





At all times: 8 C-C*OOH ~ C*15-C*00 H II2.5%RCAI 
E l  
complex llpids 
$ 
Later: C*I7-COOH ~ C-COOH + C*I5-C*0OB 
Fro. L Sequence of events in brain following 
intraperitoneal injection of aeetate-l-Clt 
sumably feeding FA into the free FA pool 
Moreover, recent experiments with microsomal 
FA synthesis indicate that the newly syn- 
thesized FA are immediately incorporated into 
complex lipids, rather than released as free 
FA. One might therefore expect that the chain 
elongation enzymes would have available pre- 
formed, nonradioactive 16:0. The above hy- 
pothesis is summarized in Figure 1. 
We have obtained the expected data in the 
case of 16:0 and 18:0 of the total brain lipids 
(11). Here, the RCA of 16:0 ranged between 
12.2 and 12.9 during a 56 day Nine period, 
during which time the specific activity dropped 
31-fold. (The theoretical value : ~/s ---- 12.5%.) 
Meantime the 18:0 RCA dropped from 20.7 
at 4 hr to 6.0 at 56 days (de novo value = 
11.1%). Evidently all or most of the 16:0 
and 18:0 fit the pattern predicted above. 
Relative Carboxyl Activities of Ganglioside 
Stearate 
Three groups of young rats were injected 
with acetate-l-C 1", then killed in subgroups of 
five at various time intervals (see Fig'. 2). The 
three groups differed in their initial ages: 7, 
13, and 22 days, chosen to represent the be- 
ginning of myelination, tile time of most 
active myelination, and the point of slowing 
myelination. The brains of all five rats in 
each time point were pooled and the 18:0 was 
isolated from the gangliosides and decar- 
boxylated (17). Figure 2 shows the RCA's 
obtained at each time point. I t  is evident that 
ganglioside 18:0 follows the predicted pattern 
of chain elongation from 16:0 and that there 
2 5  I I I I I l l l l l  I I l I [ 1 1 1 1  I J 
2o ?..~C..~..~..,~..~. 
a , ~ . ,  ".,%. 
15 A ~ , ~  ~ "~ M 
OE NOVO VALUE "~__''0~_ " .  -I 
I0 -~ "-~. 
-t 
0 I I I I I I l l l l  I I I I I I I I I  I I ' ~  
4 h  2 d  I O d  3 0 d  
T I M E  
FIG. 2. Relative radioactivity in earboxyl car- 
bon of ganglioside stearate as a function of age. 
A, rats injected at 7 days of age; B, rats in- 
jected at 13 days; C, rats injected at 22 days. 
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is no qualitative difference in mode of synthe- 
sis in the three age groups. 
The older animals show higher RCA's at 
each time point, probably because the turnover 
rates of the F A  are slower in the older 
animals. 
Kelative Carboxyl Activities of the 
Cerebroside Nonhydroxy l~atty Acids 
Table I shows the results of two studies in 
which rats were given acetate-l-C ~ and the 
eerebroside lignocerate (24:0) was isolated and 
decarboxylated. The de hove value for 
lignocerate RCA is 1/12 = 8.3%. I t  can be 
seen that high RCA's were found in the early 
time points, as with ganglioside and total brain 
18:0, and the RCA's declined with time. How- 
ever, only the youngest group of rats showed 
RCA's below the de novo value, evidently be- 
cause of a considerable decrease in turnover 
rate with increasing age. I t  is evident that 
cerebroside 24:0 is made by chain elongation. 
Fulco and Mead carried out a similar study 
(9), killing at only one time point, and found 
an RCA for 24:0 of 10.31. Since this is 
moderately close to the de hove value of 8.3% 
they concluded that 24:0 is made directly from 
acetate, with little preliminary formation of 
shorter acids. In  one of our experiments with 
rats of the same age (line 1, Table I ) ,  we 
found a similar value after two days (9 .41) ,  
but it is evident that this is only a coincidence 
of timing. 
We also examined the 18:0 from cerebrosides 
in the above experiments and here (Table I I )  
the RCA's come rather close to the de novo 
value (11.11).  0n ly  one point (18.21) in- 
dicates the existence of chain lengthening. 
There is thus good reason to believe that the 
]8:0 used for cerebroside synthesis is made by 
a hitherto uncharacterized synthetic system. 
Sphingosine (3), psychosine (6), and cere- 
broside (1) are made by microsomes, which 
are also known to utilize acetate to make 
labeled complex lipids (28). I t  is thus quite 
TABLE I 
Rela t i ve  Carboxy] Ac t iv i ty  in Biosyn thes ized  Cerebrosldo 
L i g n o c e r a t e  fo l lowing  In j ec t i on  of Ace ta t e - l -C  1~ 
Age of r a t s  T i m e  of sacr i f ice  a f t e r  i n j ec t ion  
a t  t ime  of 
in jec t ion  4 h r  1 0 h r  2 d 4 d  10 d 2 8 - 3 0 d  5 6 d  
Days  
13 13 .4  - -  9 .4  - -  6 .5  5 .5  - -  
22 18.2  - -  13 .6  - -  12 .1  11.2  - -  
23 15.7  15.6  - -  13 ,1  - -  8 .1  7 .8  
F i r s t  2 l ines  a re  p a r t  of one expe r imen t  (17); l as t  
l ine is p a r t  of ( 1 1 ) .  D a t a  a r e  in  percen ts .  
possible that these particles make 18:0 de nero 
and elongate it to form 20:0, 22:0, etc. Liver 
microsomes can convert malonyl-CoA to FA, 
mainly to 18:0 rather than 16:0 (28), and it  
would be of interest to isolate these particles 
after in vivo administration of labeled acetate 
to see if the microsomal lipids, freshly formed, 
contain uniformly labeled 18:0. 
Direct ~.vidence for Chain Lengthening in 
Sphingolipids 
Additional evidence for the chain elongation 
system was obtained by injecting emulsions of 
palmitate-l-C 1' and stearate-l-C 1' directly into 
the brains of 22-day-old rats (12). The major 
sphingolipids (cerebrosides + sulfatides + 
sphingomyelin) were isolated from the brains 
24 hr later and their FA were decarboxylated. 
The 16:0 isolated after palmitate-C 1' injection 
contained nearly all its radioactivity in the 
original position (96% RCA), showing that 
degradation to acetate and resynthesis of 16:0 
(12.51 RCA) was a minor route, and that 
part  of the injected FA was incorporated into 
the sphingolipids. Similarly, the 18:0 isolated 
after stearate-C :' injection was incorporated 
very directly, too (97% RCA). 
The 18:0 isolated after p a l m i t a t e - C  1" injec- 
tion was rather highly labeled and its RCA 
was 3%. Evidently the injected 16:0 was 
elongated with acetate that was relatively non- 
radioactive. The 16:0 isolated after s teara te -  
C 14 injection was not highly labeled, evidently 
because it was made purely by fl-oxidation of 
18:0 to acetate, followed by de novo formation. 
The RCA for this 16:0 was 15%, a little too 
high for the de novo value (12 .51) ;  it is 
likely that a small amount of highly labeled 
18:0 (97% RCA) contaminated the 16:0 dur- 
ing GLC. 
Radioactivity was also found in 22:0 and 
24:0 of the sphingolipids and here the RCA's 
were 3-5% with both groups of injected rats. 
This is direct evidence showing that both 16:0 
and 18:0 can be elongated to 22:0 and 24:0, 
the elongation having taken place with acetate 
of relatively low specific activity. 
T A B L E  II 
Rela t i ve  Carboxyl  Ac t iv i ty  in  Cerebros ide  S t e a r a t e  foI- 
lowing' I n t r a p e r i t o n e a l  I n j ec t i on  of Ace ta te - l -C  1~ 
Age of r a t s  T i m e  of sacr i f ice  a f t e r  i n j ec t ion  
at  t ime of 
in jec t ion  4 h r  1 0 h r  2 d  4 d  1 0 d  2 8 - 3 0 d  5 6 d  
Days  
13 11 .7  - -  9.8 - -  10.8  9.4 - -  
23 18.2  10.9  - -  11.2  - -  10 .9  10.2  
F i r s t  l ine  f rom ( 1 7 ) ,  second l ine  f rom ( 1 1 ) .  D a t a  
a re  in  pe rcen t s .  
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l~ormation of the Odd-Numbered l~atty Acids 
The major odd-numbered Nt~A in the glyco- 
lipids are 23:0 and 25:1, with smaller amounts 
of 23:1 and 25:0. Small amounts of 15:0 and 
17:0 occur in brain and elsewhere, and the 
results of in vitro work with those acids in- 
dicate that they are made by the same de novo 
system that makes 16:0 (4). The only dif- 
ference is that the starting substrate is 
propionyl-CoA instead of acetyl-CoA. To see 
whether a similar system exists in brain, we 
injected propionate-l-C ~ intraperitoneally into 
a group of rats, then isolated the saturated 
NFA from the cerebrosides (10). 
The data showed that the odd-numbered 
acids exhibited the highest specific activities by 
far. Similar results were obtained when the 
total brain FA were isolated, in which case 
15:0 and 17:0 had much more activity. In  
view of the previously described data for the 
even-numbered acids, it seems very likely that 
15:0 and 17:0 are made from propionate + 
~cetate (malonate) and that these are elongated 
with C~ residues to form the ~onger odd- 
numbered FA so characteristic of the 
glyeolipids. 
Evidence for a second route of biosynthesis 
is presented later. 
Formation of the Unsaturated Sphingolipid 
Acids 
Surprisingly little is known from in vitro 
work about the mode of formation of the 
unsaturated acids. For  many years the basic 
fact was known that 18:0 can be desaturated 
to form 18:19 and it appeared likely that 16:0 
is desaturated simi~arly, to form 16:1 ~ (palmi- 
toleate). Presumably the same enzyme acts on 
both substrates, renmving two hydrogen atoms 
in both cases at the 9,10 position (counting 
from the C 0 0 t t  end). In  the case of the 
longer unsaturated NFA of the glyeolipids, 
one would expect this enzyme to form 24:1 ~, 
26:1', etc., from the saturated analogs. ]-Iow- 
ever, the only isomers of known structure at 
the time we began this study were 24:1 ~ 
(nervonate), 22:1 ~*, and 20:l~L From this 
observation it woul~ appear unlikely that 
desaturation of long FA takes place. 
Examination of the sphingolipid unsaturated 
F A  from a different viewpoint--from the 
methyl or ~ end--places the acids in a more 
coherent system. I f  we locate the double bonds 
by counting from the o~ end, we find that they 
are all in the oleate family: 18:1~9, 20:1o~9, 
22:1~9, and 24:1~9. I t  is then reasonable to 
assume that the chain elongation system used 
by the brain to make the glycolipid acids acts 
similarly on oleate. 
Fulco and Mead, in the same labeled acetate 
experiment mentioned above (9), isolated 
nervonate and deearboxylated it. Its RCA was 
20.2%, much different from the 10.3% they 
found for the saturated analog. Since they 
had concluded that tile latter is formed by 
de novo synthesis, they then concluded that 
24:1 is formed by the alternative method, 
chain elongation. Noting the above-mentioned 
similarity in double bond position, they sug- 
gested oleate is the precursor of ne~wonate. 
We sought to make a direct demonstration 
of the conversion by injecting oleate-l-C 1. 
directly into rat brains, as in the labeled 
palmitate and stearate experiments. The re- 
sults were somewhat different (22), for the 
long unsaturated FA showed very high RCA's: 
74% for 24:1, 53% for 22:1, and 86% for 
20:1. An additional surprise is that relatively 
little of the injected oleate was incorporated 
into the sphingolipids. Par t  of the explanation 
for the latter finding is that 18:1 is a very 
minor acid in this group of complex lipids, 
and it apparently turns over very slowly 
(if at all). 
I t  would appear from the above results 
that very little of the injected oleate entered 
the cells making nervonate, etc., and much of 
the 18:1 was simply oxidized to ~eetate-t-C "~. 
The acetate did enter the synthesizing cells and 
was used to elongate the 18:1 already present 
in the cells, t towever~if labeled acetate were 
used to elongate only 18:1, the resultant 24:1 
would have 1/3 of its C ~' in its COOH group 
(since three C~ units are needed). Since the 
RCA ~or 24:1 was far above 33%, it must be 
made in part  by elongation of 22:1 and 20:1. 
Evidently the sphingolipid-synthesizing cells 
contain pools of 22:1 and 20:1, as well as 
]8:1, all of which can be used for chain 
elongation. I t  is likely that similar pools of 
saturated FA are also present. 
Evidence from Ozonolysis of the Sphingolipid 
Acids 
Palmitoleate, 16:1~o7, exists in brain, albeit 
in much lower concentrations than oleate, and 
it too should be subject to chain elongation if 
the elongating enzymes are not too specific. 
]7:1 also exists and should give rise to the 
odd-numbered unsaturated FA, none of whose 
structures was known. In  order to confirm 
these guesses, we processed pig brains to 
isolate the sphingolipids and their individual 
unsaturated FA. GLC yielded these acids as 
single peaks which showed the expected in- 
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frared absorption spectra for cis-FA. A micro- 
ozonolysis procedure was devised (21) which 
permitted quantitative determination of the 
fragments of each FA isomer, starting with 
1.5-3 mg of sample. The results of analyzing 
the nlono- and diunsaturated FA are shown in 
Table I I I ,  which gives the abundance of each 
isomer, classified according to its (o-family. 
Sinlilar data are shown for the H F A  from the 
same brains (23). 
The number of isomers found within each 
chain length was unexpectedly large; most of 
these had previously not been reported in 
nature. The existence of even- and odd- 
numbered diunsaturated FA in the sphingo- 
lipids is also of interest. 
The ~6 family occurs only in the dienes and 
is evidently due to chain elongation of linoleate. 
The (o7 family is found in all of the acids 
and presumably arises from pahnitoleate. 
Elongation of 16 : le7 should give rise to 18:1~7 
(cis-vaccenic acid) as well as the longer mem- 
bers of this family. Cis-vaceenic acid does in- 
deed exist in brain, as we found in a later 
study (24) of the ester-baked F A  of pig 
brain. While this acid had been known to 
occur in animals for some time, it was con- 
sidered a rare acid. However, we found this 
to be the second most common monounsaturated 
FA, second only to oleate and nmch more 
abundant than palmitoleate. As was shown 
very recently in vitro (15), cis-vaccenate is 
formed by elongation of palmitoleate, con- 
firming our suggestion that the latter is 
elongated to form a series of (o7 FA. 
The odd-numbered acids of the ~7 family 
may be presumed to originate from the even- 
numbered members by 1-carbon degradation 
according to the hydroxylation-oxidation sys- 
tem described in a later section of this paper. 
The occurrence of the cos family only in the 
odd-numbered FA must mean that these acids 
are formed by elongation of a p~mary  acid, 
17:1~8. This acid is presumably formed by 
desaturation of 17:0 at the 9,10 position. 
The oleate, or (o9 family of acids is like the 
(o7 family in that it is represented in all chain 
lengths and in the dienes. These acids are 
probably formed by elongation of oleate and 
the odd-numbered acids are formed by 1-carbon 
degradation of the longer acids. Thus all of the 
above unsaturated acids may be considered 
as arising initially from the desaturating 
enzyme which acts on the 9,10 position from 
the COOH end of 16:0, 17:0, and 18:0. 
The (ol0 family of Table I I I  can probably 
be explained as arising by elongation of 
16:1~10. The odd-numbered acids presumably 
are formed from the longer acids (26:1(o10 
and 24:1~10) by the 1-carbon degradation 
system. The postulated "primer" acid, 16:1~10, 
was found in the ester-linked acids (24) as 
was a long line of longer col0 FA. Perhaps 
another desaturating enzyme exists in brain 
which is specific for the 6,7 position of FA 
(counting from the COOH end). 
The above hypotheses are based on the 
assumption that the chain elongating enzymes 
can act on 16-,17-, and 18-carbon FA as their 
"primer." This is consistent with our previous 
proposal that 18:0 is made de novo in micro- 
somes and lengthened to form the cerebroside 
acids and with the results cited above with 
intracranial injection of labeled 16:0 and 18:0. 
FA desaturation of 18:0 takes place in 
microsomes (29). 
The role of palmitoleate in chain elongation 
was demonstrated by ozonolysis of the 24:1 
isolated in the previously described experiment 
(22) in which oleate-l-C ~ was injected into 
rats intracranially. The 24:1 yielded two di- 
carboxy acids, C~ and C,~, and two monocar- 
T A B L E  I I I  
O c c u r r e n c e  of t h e  U n s a t u r a t e d  F a t t y  A c i d s  of P i g  B r a i n  S p h i n g o i i p i d s  
F a t t y  
a c i d  
f a m i l y  a 
M o n o u n s a t u r a t e d  f a t t y  a c i d s  D i u n s a t u r a t e d  a c i d s  
2 2 : 1  2 3 : 1  2 4 : 1  2 5 : 1  2 6 : 1  2 4 : 2  2 5 : 2  2 6 : 2  
w6 N F A  . . . . .  1 .9  0 . 1 4  
w7 " 2 1  4 , 5  4 4  3 .7  13 0 .3  0 . 0 7  
w8 " - -  2 . 7  - -  1 .3 - -  - -  - -  
w9 " 3 .7  1 ,5  1 7 0  10  10  0 . 4  0 . 0 6  
0)10 " - -  0 ,1  4 . 4  1 .3  2 .9  - -  0 . 0 1  
w7 t t F A  3 .2  1 . 6  33  3 .8  J 8  
w8 " - -  0 . 7  - -  0 . 7  - -  n o t  i s o l a t e d  
w9 " 0 .5  0 . 4  4 4  2 . 8  7 .3  
wlO " 0 .1  0 . 0 3  3 .2  0 .2  1 .0  
0 . 1 4  
0 . 2 2  
0 . 1 3  
0 . 0 2  
a P o s i t i o n  of d o u b l e  b o n d  c o u n t i n g  f r o m  t h e  m e t h y l  e n d .  I n  t h e  ca se  of t i l e  d i u n s a t u r a t e d  F A ,  i t  
i n d i c a t e s  t h e  p o s i t i o n  of t h e  d o u b l e  b o n d  c lo se r  to  t h e  m e t h y l  end ,  
D a t a  a r e  i n  m g  F A / 1 0 0  g' f r e s h  b r a i n .  
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boxy acids, 7:0 and 9:0. The distribution of 
activity in the original 24:1 isomers was as 
follows : 
co9 isomer (nervo~aate) : 
~ - -  18 cpm \ f ~ 3450 e p m - - - x  
"CH~-- (CH~) ~--CH~--CHe--CH-----CH-- (Ctt~) ~a--COOH 
~ isomer  : 
s - - - O  c p m - - \  / IB3 cpm x 
Clala - (CI-I~) s-- 0 t I~--CIt - -Gt t=--CIt  z-- (OHm) la- -COOtt  
These data are consistent with the idea that the 
injected oleate was primarily oxidized to ace- 
tate, which was then used to elongate non- 
radioactive palmitoleate and oleate. 
FORMATION OF THE 2-I~YDROXY 
PATTY ACIDS 
Studies with Labeled Acetate 
Fulco and Mead, in the same experiment 
mentioned (9), carried out the first examina- 
tion of eerebronie acid (h24:0). They injected 
aeetate-l-C ~ intraperitoneally into 13-day-old 
rats and isolated brain h24:0 (as well as 24:0). 
Deearboxylation of the H F A  yielded ~t RCA 
of 19~3%, identical to that of the 24:0. Indeed 
the C ~ distribution in the first 3 carbon atoms 
of each acid showed very similar patterns. 
From these relations, and the finding that 24:0 
had 16 times the specific activity of h24:0, they 
concluded that the H F A  was probably made 
from the analogous NFA. 
The force of the conclusion was weakened 
by the mode choser~ for administering tLe 
isotopic acetate. The acetate was injected in 4 
daily doses and the animals were killed 3.5 
hr after the last dose. Reiner (38) has pointed 
out the difficulties that ensue from such a 
dosage plan, but the mat hemattcal treatment 
of the problem was a formidable one. A 
simpler approach can be made by considering 
what would happen if one were to give an 
animal acetate-~-C ~ for several months during 
its early life. I t  seems very likely that each 
FA molecule in the animal would become 
uniformly labeled (in the odd-numbered posi- 
tions) and would reveal a RCA corresponding 
to the theoretical de novo value~ even if the 
acid had been made by chain elongation. 
Lignocerate, for example, is made from 16:0 
or 18:0 and aceta[e, MI of which would ha'~e 
the same specific activity. 
In  the more typical 1-pulse type of isotope 
experiment, the molecules of 24:0 formed at first 
are made from highly labeled acetate and rela- 
tively unlabeled 16:0 or 18:0. A second pulse 
of labeled acetate would find itself adding on 
to 16:0 which is now more radioactive. Each 
successive pulse maintains the specific activity 
of the br~in acetate, which is now adding on 
to highly and similarly labeled 16:0. The 
Fuleo-Mead experiment was concluded shortly 
after the last injection, while the brain 16:0 
was still at a high level of activity. Under this 
condition one would expect to find a RCA for 
czech brain acid (or any other I~A made from 
a slowly metabolizing ~'A) close to its de 
novo value. Indeed, Fulco and Mead con- 
firmed this in a later analysis os the 18:0 
from these rat brains (31). Here the RCA 
was 12.7% for cerebroside 18:0 and 11.7% 
for ester-linked 18:0 (de novo = 11.1%). 
They concluded from this that all brain 18:0, 
like 24:0, is made from acetate without dilution 
with inactive 16:0. 
The liver 18:0 from the same rats showed a 
RCA of 30%, which indicates chain elongation 
must have taken place. Why the difference 
between brain and liver? FA metabolism is 
undoubtedly much faster in liver so that the 
16:0 fornmd after the first ~ isotopic injections 
had already turned over and lost much of its 
radioactivity by the time the last pulse of 
acetate was administered. Thus this experiment 
with respect to liver was much like a typical 
1-pulse experiment; during the 3.5 hr following 
the last injection the labeled acetate was adding 
on to relatively nonradioactive 16:0, producing 
18:0 with a high RCA. 
I t  should be evident from this discussion 
that the data resulting ~rom a multipulse ex- 
periment can be misleading when tile animals 
are sacrificed shortly after the last injection. 
As part  of our time study of the NFA of 
brain cerebrosides formed from labeled acetate 
(11), we also isolated the major saturated 
HFA.  The RCA's of 24:0 and h24:0 were 
quite similar throughout the period examined, 
4 hr to 56 days (see line 3 of Table I for the 
24:0 data). This relation is consistent with 
the idea that 24:0 is the precursor of h24:0 
(or vice versa). A probable sequence of 
events in this ease is: 
9 aeetates -----------> 1 8 : 0  
18 :0  + 3 acetates ~ 2 4 : 0  
2 4 : 0  ~- psychosine ~ 2 4 : 0  cerebroside 
~ h ~ 4  -4- psyeh~s~ne 
h 2 4 : 0  ~erebroside 
I f  the 2 cerebrosides, kerasin and cerebron, 
had somewhat different rates of synthesis and 
breakdown one would find the RCA's diverging 
with time. This follows from the fact that 
the RCA of a group of molecules is the 
average of the RCA's of the individual mole~ 
cules. As new molecules of 24:0 and h24:0 
are deposited in cerebroside form, they modify 
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the average RCA of the previously deposited 
molecules at similar rates. 
Evidence from Intracranial Injection 
As in the previously described experiments 
utilizing intracranial injection of labeled 16:0 
and 18:0, we also injected lignocerate-l-C ~* and 
cerebronate-l-C ~ (12). In  the case of the 
former compound, only the 24:0 and h24:0 of 
the cerebrosides were found to be highly 
labeled. (Unsaturated acids were not isolated). 
The RCA of the isolated h24:0 was 89%, 
which means that most of the eerebronate was 
made quite directly from the 24:0, although 
some must have been made from 24:0 foI'med 
endogenously from labeled acetate (itself de- 
rived by fl-oxidation of some of the injected 
24:0). 
The reverse reaction apparently does not go, 
at least under these conditions. Almost none of 
the cerebronate radioactivity found its way 
into the NFA although incorporation o2 the 
cerebronate into the sphingolipids was observed. 
Since the reaction probably is carried out 
by the microsomes, which are noted for their 
ability to hydroxylate substrates, it is likely 
that the reaction involves a direct hydroxyla- 
tion in the 2-position. However, there is the 
possibility that the NFA is first dehydrogenated 
in the 2,3-position, then hydrated in the 
"unnatural" direction. 
A preliminaz T note has appeared on an 
enzyme system in plants which converts 16:0 
to h16:0 and then to 15:0 (14). 
The Unsaturated Hydroxy Acids 
Of two possible synthetic routes: 
~- O2 
u n s a t u r a t e d  FA~ > n n s a t n r a t e d  H P A  
- - 2 H  
s a t u r a t e d  H:~'A > u n s a t u r a t e d  H ~ A ,  
it is likely that the first is the actual one. The 
evidence presented earlier in this paper showed 
that it is likely that the unsaturated NFA are 
made by chain elongation of the medium 
length unsaturated NFA. I t  is these acids 
which are probably hydroxylated. 
]~urther evidence comes from examination 
of the double bond positions in the t I F A  of 
brain (23). As described before, pig brains 
were processed to yield the individual un- 
saturated t I F A  (homogeneous with respect to 
chain length) and these were then examined 
by ozonolysis to determine the amounts of 
each unsaturated isomer. The even- and odd- 
numbered H F A  between h22:1 and h26:1 were 
studied (Table I I I ) .  Each acid contained a 
member of the ~7 family and the ~9 family, 
presumably derived by elongation of palmit- 
oleate and oleate followed by hydroxylation. 
Also present, but only in the odd-numbered 
HFA, were members of the ~8 family. As 
explained before, these are probably formed by 
elongation of 17:1o)8. 
Trace amounts of the col0 family were also 
found, as in the unsatmxted NFA. Again the 
evidence points to simple hydroxylation of the 
analogous unsaturated NFA. 
There is a marked difference between H F A  
and NFA in the relative abundances of the 
~o7 and r families. The total amounts of the 
two families in the H F A  are 00 and 55 mg/]00 
g brain, respectively; in the NFA they are 86 
and 195 rag/100 g brain. Perhaps this reflects 
a tendency of the hydroxylating enzyme to 
prefer FA having a longer saturated chain 
next to the C 0 0 I t  group. This preference is 
shown also in a comparison of the relative 
abundances of the NFA and H F A  of all the 
sphingolipid acids of the same pig brains 
(Table IV).  Here we see that the relative 
amount of H F A  rises with increasing length 
of the CH: chain next to the COOH group 
(26:0 is a minor exception). 
THE 1-CARBON DEGRADATION SYSTEM 
Evidence from Degradation Experiments 
In  one of the turnover experfinents described 
above (11), in which weanling rats were in- 
jected with acetate-l-C ~, the cerebroside h23:0 
acid was isolated and decarboxylated. As pre- 
dicted from the elongation theory, the RCA 
was high in the early time points and low 
in the late time points. Indeed, the RCA went 
to the lowest obse~ced value in this study, 
2.9%. From this it would appear that an odd- 
numbered FA, probably 17:0, is formed first 
T A B L E  IV 
Rela t ive  A b u n d a n c e s  of H y d r o x y  and  Nonhydroxy  Acids  
in  P i g  B r a i n  Sph ingo l ip ids  
Iqumber  of CH2 
g roups  a t t a ched  R a t i o  of  
Acid  type to C O O H  group  a H F A / N F A  
22 l~[onoenes 14 0 .15  
23 " 15  0.Z1 
24 14 0 .35  
25 17 0 .88  
26 " 18 0 .97  
22 S a t u r a t e d s  21  1.6 
23 22 2.1 
24  23 2.1 
25 " 24  2.3 
26 25 1.5 
a Ca l cu l a t ed  for  the  m a j o r  i somer  
monoenes  ( in  the  case of 2 5 : 1  the  
is w9 and  the m a j o r  t tFA.  i somer  
de r ived  f rom Table  I I I .  
i n  the  case of the  
m a j o r  N F A  i s o m e r  
is w7) .  D a t a  a r e  
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T A B L E  u 
D i s t r i b u t i o n  of R a d i o a c t i v i t y  i n  t h e  I n d i v i d u a l  C a r b o n  
A t o m s  of C e r e b r o s i d e  A c i d s  a f t e r  I n j e c t i o n  of 
A c e t a t e - l - C  14 
A g e  of r a t  a t  
t h e  t i m e  of  C a r b o n  a t o m  n u m b e r  a 
- -  F a t t y  a c i d  
I n j e c t i o n  S a c r i f i c e  d e g r a d e d  2 0  2 1  2 2  2 3  2 4  
23  d 51  d h 2 3 : 0  8 .5  4 .3  - -  
23  d 7 9  d h 2 2 : 0  - -  1 .4  9 .1  
h 2 3 : 0  8 .3  2 .9  - -  
h 2 4 : 0  0 .8  8 .4  
1 5  d 1 6 8  d h 2 3 : 0  - -  2 .8  5 .8  0 ,3  - -  
h 2 4 : 0  - -  1 .0  5 .3  0 . 6  9 .3  
2 3 : 0  6 . 4  1 .9  4 . 9  0 .8  - -  
a C o u n t i n g  f r o n l  t h e  m e t h y l  e n d  of t h e  FA. 
D a t a  a r e  i n  p e r c e n t  of  a c t i v i t y  i n  t h e  c a r b o n  a t o m  
c o m p a r e d  w i t h  t h e  e n t i r e  m o l e c u l e .  T h e  l o w e r  t h r e e  
l i n e s  a r e  f r o m  ~YIead a n d  L e v i s  ( 3 2 ) .  
and is then elongated with 3 acetate residues 
to form 23:0, which is then hydroxylated. The 
rapid drop-off in RCA suggests that this acid 
has a high turnover rate. However, the total 
radioactivity per brain in cerebroside h23:0 
showed the most prolonged rise with time of 
all the cerebroside acids, which suggests that 
this acid undergoes little or no breakdown. 
Moreover, the deposition in brain of h23:0 is 
the most prolonged and striking, which could 
mean that this acid does not undergo metabolic 
attack. 
The conflicting pieces of evidence were 
clarified by degrading the h23:0 further to 
learn the relative activity of carbon 2. The 
data are shown in Table V and include similar 
degradation data for h22:0 and h24:0. By 
looking at lines I and 3, we see that the second 
carbon atom of h23:0 (analyzed at 2 different 
time points) has an unexpectedly high amount 
of C 1~. I f  h23:0 were made only by elongation 
with acetate-l-C", the a-carbon atonl should 
contain virtually no radioactivity. Indeed, 
analysis of the even-numbered H F A  (lines 2 
and 4) does show there is little C 1~ in the 
a-atoms. (There should be even less, according 
to the elongation theory.) The most plausible 
explanation of the unexpected finding is that 
part of the h23:0 is made by a 1-carbon deg- 
radation of h24:0. The fi-carbon of h24:0, 
which should have a C 1~ content similar to 
that of the COOH carbon, becomes the a-carbon 
of h23:0 and the a-carbon of h24:0 becomes the 
COOH of h23:0. 
The relative activities in the individual 
atoms are shown in Table V in columns which 
align the data for identical atoms. 
The 1-carbon degradation scheme is shown 
in Figure 3. 
I t  is very likely that part  of the h23:0 is 
further degraded to h22:0. This explains the 
small but appreciable activity in the a-carbon 
of the latter acid. (An alternative explanation, 
which must account for part  of the activity in 
the a-atoms of all FA, is that part of the 
injected acetate is metabolized to labeled CO~, 
and part  of this finds its way to form acetate 
labeled in the methyl position. Such acetate, 
during chain elongation, would yield FA con- 
taining some C ~~ in the even-numbered carbon 
atoms.) 
Mead and Levis (32) carried out a similar 
experiment which is also summarized in Table 








c2 ) _ c2 ) C21-C*00H ) C21-C*H2-CH2-C*OOH -~ 
, , , , / \  ,. _ oo. + C21-C*H2 - H--C*OOR 
.:o T I x: 
C21- le*H-COOH C21-C*It2-~ - c * O O H  
OH 
\ /  
J I 
+ 7 ~C._CH2_C.OOH 2 ) 19:0 2 ) 21:0 1 I C21-CH2-C*00H ] ~ 25:0 
C C C 2 C21-C*H2-COOH C2 
C3 C2 i~ 
,oo \i ~ ,,~ 
\, 
C21-COOH + C*O 2 
FIG. 3. Formation of the odd-numbered fatty acids by two biosynthetic routes. 
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V (last 3 lines). Substantially the same re- 
suits were found. Incidentally, their RCA for 
h23:0 was even lower thai~ ours, evidently 
because the rats were kept for a much longer 
period before sacrificing. 
Evidence from in Vitro Work 
Following this decarboxylation study, Levis 
and Mead succeeded in demonstrating the 1- 
carbon degradation reaction in vitro (27). 
They showed that h18:0 and h23:0 are de- 
graded by rat brain mierosomes to form COs 
and the acid with one carbon atom less. ATP 
and NAD are necessary for the system as well 
as unknown material found in the cell superna- 
tant. They found that k18:0 (2-ketostearate) 
was also attacked by the enzyme system, some- 
what more rapidly than the h18:0. Presumably 
the hydroxy acid is deearboxylated via the 
keto acid as intermediate. 
At the kind invitation of Dr. Mead, the 
senior author and Dr. Amiya Haj ra  spent a 
month at his laboratory to become familiar 
with the problem. We have since been studying 
the enzymatic attack of the brain enzymes on 
k18:0. Drs. S. S. Parmar and W. E. Davies 
have also worked in this laboratory on the 
problem, using an acetone powder of pig brain 
as the enzyme source and following the re- 
action by measuring the C~O~ produced from 
the keto acid. 
I t  appears that the same cofactors are 
needed for k18:0 and h18:0 oxidation: ATP, 
NAD, and cell supernatant. Par t  of the 
activity in the cell supernatant is removed by 
Dowex 50-It*; this seems to be 1Kg § Another 
part is removed by Dowex 1-OAc-; this can 
be recovered from the resin by elution with 
dilute acid. The acidic cofactor is stable to 
heat in acid but not in alkali and shows the 
properties of ascorbie acid. Synthetic ascorbic 
acid does replace the acidic cofactor but is 
inhibitmT at higher concentrations. The opthnal 
concentration in our system is 5 • "10 ~ M, 
which is unusually low for ascorbic-catalyzed 
enzyme reactions. 
The complete enzyme system, containing 
ATP, NAD, aseorbate, and Mg §247 is seriously 
inhibited by an iron chelator (o-phenanthroline) 
or by the more general chelator, EDTA. The 
EDTA effect is not reversed by washing the 
particulate enzyme with water unless ferrous 
chloride is added, so it appears that bound 
Fe § is also needed for activity. 
Incubation under nitrogen drastically lowers 
activity. Further evidence that the reaction is 
oxidative was obtained by isolating the non- 
radioactive product, 17:0 acid, by means of 
TLC and GLC. The enzyme preparation itself 
contains some free FA (even-numbered), so 
no carrier was needed. We did add 16:0 alde- 
hyde before isolating tile lipoidal products, but 
reisolation of the aldehyde showed only one 
peal< (16:0) on GLC. 
TURNOVER OF THE GLYCOLIPID I~ATTY 
ACIDS 
Turnover data normally consist of measure- 
ments of the activity of compounds which are 
isolated from animals previously injected with 
a single dose of a radioactive precursor. The 
animals are sacrificed at various times after 
the injection mid the activities are plotted 
against time. In  order to minimize individual 
variation among animals and obtain smooth 
curves, one must sacrifice groups of animals 
at each time point. Thus such experiments 
tend to involve a great deal of effort and radio- 
active material. They are carried out because 
they yield information that cannot be obtained 
in other ways. 
3 / I  x . 
/ x 18:0 
/ ~ ~ 22:D 2 / 
I :0 
_ I I I I 
0.33 0.5 1 2 4 8 14 28 
DAYS 
3 ~ ~ 22:O 
I 
4 14 28 56  
DAYS 
Fro. 4. Tota l  act iv i ty  per b ra in  in  N F A  o f  
cerebrosides. Upper figure, rats injected with 
trltlum-labeled acetate. Lower figure, rats in- 
jected with COOH-labeled acetate. (From ref. 11, 
reprinted by permission of the publisher.) 
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The Cerebroside Fatty Acids 
Figure 4 shows the results of administering 
a single dose of aeetate-2-H* (upper curves) 
or acetate-l-C ~' (lower curves) to male weanling" 
rats, then isolating the eerebroside • (11). 
Let us examine the curves singly, from the 
top down. 
The curve for 24:0 shows a maximal value 
was reached soon after tile injection, at ap- 
proximately 4 hr. (The zero point is not 
shown because the data are plotted on semilog 
paper). The activity then declined rapidly, 
showing rapid metabolism of the cerebroside- 
bound 24:0. Whether the metabolism involved 
hydrolytic breakdown or, perhaps, sulfation 
to form sulfatide, we cannot tell from these 
data. A second rise in activity appears, much 
more gradual, reaching a peak at roughly 14 
days. Again the activity drops off, also much 
more gradually than the first time. The 
presence of two separate turnover patterns for 
one substance must mean that we are observing 
two pools of 24:0 eerebroside (kerasin). The 
first peak shows there is a pool of kerasin in 
brain which is formed and destroyed rapidly, 
with a half-life of roughly one third of a day. 
The second peak shows there is a pool with a 
much more leisurely breakdown rate. Since 
we did not prolong the experiment tong 
enough we must consider the possibility of a 
third pool which might not, perhaps, undergo 
any breakdown at all. 
The first pool of 24:0 is made from 16:0 
and/or  18:0 by elongation with highly radio- 
active acetate. Since the tritimn-labeled acetate 
is known to undergo very rapid oxidation to 
T._,O and CO~, the slowly metabolizing 24:0 
must be made from some other radioactive 
precursor. As our decarboxylation and other 
experiments showed, this radioactive precursor 
must be labeled 16:0 or 18:0, formed in the 
initial hours from labeled acetate. The labeled 
medium-length FA are in large part  incor- 
porated into the glycerophosphatides, which 
show a more rapid metabolism than the cere- 
brosides (11). As the phosphatides undergo 
breakdown, the liberated FA are in part  
utilized for chain elongation to form 24:0. 
Thus the precursor FA pool loses activity only 
quite slowly and continues to add tritium over 
many weeks to the even more slowly metaboliz- 
ing cerebroside pool. 
I t  is tempting to assign the slowly metab- 
olizing kerasin to myelin and the rapidly 
metabolizing kerasin to the other structural 
elements of the brain. Alternatively, the 
rapidly metabolizing kerasin could be in the 
gray matter and the other pool in the white. 
Several workers, including our own group, 
have shown that cerebroside is not localized 
only in myelin. 
Let us now examine the next emwe, for eere- 
broside 18:0. This FA also shows 2 com- 
ponents, hut the second one reaches its maxinmm 
fairly soon too. I t  then shows a gradual de- 
cline in activity for the next 27 days or more. 
The difference between kerasin and 18:0 cere- 
broside is quite striking with respect to the 
more slowly metabolizing cerebroside. Perhaps 
the difference lies in a different subcellular 
distribution of the two cerebrosides, or in 
readier attack by enzymes on the less lipoidal 
18:0 cerebroside (33). 
The next 2 curves, for 22:0 and 20:0, re- 
semble the 24:0 curve somewhat. The 23:0 
curve is atypical, showing a very prolonged 
rise. The slight dip at the 28-day point may 
be due to experimental variation. This long 
period of accmnulating isotope indicates that 
a radioactive precursor is slowly being made 
available for 23:0 formation. We now know 
from the experiments described earlier in this 
paper that two long-lived precursors are in- 
volved: labeled 17:0, formed early from 
propionate and labeled acetate, and labeled 
h24:0. Both FA are made available by con- 
stant release from glycerophosphatides and 
eereblvsides. 
The lower set of curves, obtained in the C ~" 
experiment, illustrates an important point of 
general validity. Note that the very early rise 
and fall in activity seen in the upper curves 
is not visible here, except for the cerebroside 
18:0. I f  we had not run the same experiment 
with tritium-labeled acetate, we would have 
missed finding the rapidly metabolizing cere- 
brosides. The explanation for the difference 
lies in the nature of FA degradation. When 
tritium-labeled 16:0 or 18:0 is degraded by 
fi-oxidation, most of the tritimn is lost as water 
(and greatly diluted by the body water). The 
acetate residues formed in fi-degradation are 
thus only slightly radioactive so that reutiliza- 
tion of these residues will give rise to rather 
slightly labeled FA. 011 the other hand, when 
C~-labeled 16:0 or 18:0 is oxidized, the re- 
sultant acetate residues still have all their 
radioactivity. Of course much of this endoge- 
nous acetate is metabolized via the Krebs cycle, 
but still part is reutilized for FA synthesis. 
The net effect is that the radioactivity in the 
acetate-C ** pool dies away somewhat more 
slowly than that in the acetate-H a pool. This 
acts to cover up rapid changes in FA pools 
in the first day after injection. I t  is very likely 
METABOLISM OF ]~JRAIN GLYCOLIPID ~9 
that other studies of FA metabolism in similar 
experiments have missed similar disclosures of 
rapid turnover fractions because of the use 
of C ~. 
I t  should be noted also that many turnover 
studies in brain have neglected the early time 
points altogether and could not have picked 
up such fractions anyway. 
Returning to the lower part  os Figure 4 we 
see that the curves are similar to the upper 
part  with respect to the slow turaover fraction. 
This experiment covered a somewhat longer 
time period (and is plotted arithmetically), so 
the long period of decline in activity is better 
delineated. The slowness in decline of 24:0 
activity hints at the presence of a nonmetab- 
olizing fraction. Again we see that 18:0 
eerebroside oceupies a distinctly different posi- 
tion in the metabolic scheme, as does the 23:0 
eerebroside. 
Our analytical data from GLC also show 
the atypical nature of 23:0 and h23:0 cere- 
brosides, both of which accunmlate nmrkedly 
with age. Evidently the 1-carbon degradation 
system becomes a prominent system in older 
animals, in which the synthetic enzymes seem 
to slow down. 
The turnover curves for the H F A  of cere- 
brosides (not shown here) are qualitatively 
similar to those of Figure 4 except that their 
second activity peak (with aeetate-H ~) comes 
somewhat later. This is evidently due to their 
being formed from the corresponding NFA. 
In  a later study with tritium-labeled acetate 
we confirmed the existence of the rapidly meta- 
bolizing fraction and found the first activity 
maximum to be closer to 2 hr than 4. This 
fraction exists also in somewhat older rats. 
Incidentally, the sphingosine in eerebroside 
was also found to undergo tin-hover, so it is 
apparent, that cerebroside molecules undergo 
complete breakdown or are used in toto in the 
course of their metabolism. 
We also made a turnover study with aeetate- 
1-C ~ using rats os three different ages, as 
described in Figure 2. The rats were killed 
4 hr, 2 days, 10 days, and 30 days after in- 
jection and the activity incorporated into the 
eerebroside acids was measured (17). The 
highest activity was found in rats injected at 
13 days of age, when myelination is fastest. 
Some qualitative differences between the 3 
age groups were seen. A striking difference 
was noted in the 18:0 from the youngest rat 
group which did not show the rapid decline 
seen in the older rat groups. Moreover, the 
activity found in 18:0 of the youngest rats 
was higher than that found in 24:0 (in con- 
trast to the reverse situation in the older rats). 
Evidently very young rats make more 18:0 
eerebroside than 24:0 eerebroside. This find- 
ing is in agreement with that of O'Brien, who 
found 18:0 eerebroside to be somewhat more 
plentiful in early childhood (33). The same 
is true for the FA of human brain 
sphingomyelin (41). 
Another interesting observation was that the 
data from the rats injected at 7 days revealed 
the existence of the rapidly metabolizing cere- 
broside fraction even though the isotope used 
here was C% This observation is consistent 
with the suggestion that the slowly meta- 
bolizing fraction is myelin-bound. Myelin 
formation in rat  brain appears to be insignifi- 
cant until  about 9 days of age (16), so during 
the 2-day period following the C 1~ injection 
there nmst have been incorporation only into 
the labile eerebrosides and none into the myelin 
eerebrosides. 
The Sulfatide Fatty Acids 
The 18:0 and 24:0 of the sulfatide FA were 
isolated in the experiment described just above. 
As with the cerebrosides, the 24:0 activity 
curve showed a steady rise with time. Sur- 
prisingly, the 18:0 curve also showed a similar 
steady rise; indeed, in the 7-day and 13-day 
rat groups the 18:0 rose even more rapidly 
than the 24:0. In  the cerebrosides, the 18:0 
activity declined (except in the early period) 
so the difference is quite marked. The dif- 
ference may indicate e~ relatively rapid con- 
version of 18:0 cerebroside to 18:0 sulfatide. 
That such a conversion does occur was sug- 
gested by our early work with labeled galactose 
(37) and a recent report based on in vitro work 
(30). Presun~m.bly the conversion is by direct 
sulfation with phosphoadenosyl phosphosulfate. 
The Ganglioside Fatty Acids 
Virtually all the ganglioside FA are ac- 
counted for as 16:0, 18:0, and 20:0. These 
were examined as part  of the 3-age turnover 
study described above (17). The curves for 
the specific activity of 16:0 showed a very rapid 
rise followed by a fairly rapid fall. The rate 
of fall dropped off with time, particularly 
with increasing age of the rat group. Com- 
parison with the 16:0 of glycerophosphatides 
showed quite similar drop-off rates and specific 
aetivities, so this sphingo]ipid is evidently much 
more active metabolically than most of the 
other glyeolipids. A similar conclusion was 
drawn from our earlier study with galactose- 
C 1' (37). 
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The 18:0 of ganglioside yielded curves sim- 
ilar to the 18:0 of glycerophosphatides. In  
both groups of acids (with only one exception) 
the curves were surprisingly like the theoretical 
precursor-product curves predicted by Zilver- 
smit, Entenman, and Fishler (42). The 18:0 
curves rose more slowly than the 16:0 curves, 
then the latter intersected the ulaximum of the 
18:0 curves, and then the two emwes descended 
together (with the 18:0 now nlore radioactive). 
The curves are thus quite consistent with the 
elongation theory and evidence. The curves 
for 20:0 were similar to those for 18:0. 
Although ganglioside deposition slows down 
somewhat after the rat reaches 21 days of age, 
the turnover curves show that ganglioside FA 
is being metabolized even at 52 days. (How- 
ever, the 20:0 ganglioside appears to be inert 
after 32 days). 
Our turnover and decarboxylation studies 
indicate the presence of several different meta- 
bolic pools and future work must examine the 
various subeellular regions separately. 
FINAL COMMENTS 
This paper on glycolipid fatty acids was 
based primarily o n  the work of this laboratory 
and covers work by Drs. Amiya K. tIajra,  W. 
Ewart Davies, Krystyna C. Kopaczyk, and S. 
S. Parnlar. We are indebted to Dr. Benqard 
Agranoff, Coordinator of Biological Sciences 
in this Institute, for many valuable insights 
into our data. For reasons of space we ha~e 
neglected to mention relevant work from other 
laboratories. Our critical comments are of- 
fered only to clarify certain approaches to the 
study of brain metabolism and will, we hope, 
be taken good-naturedly. 
General Conclusions from Turnover Studies 
The common belief that the brain FA are 
inert arose from two observations: (1) Labeled 
precursors injected systemically into animals 
gave rise to low activities in the brain lipids; 
(2) Long-term turnover studies of brain lipids 
have shown remarkably long persistence of 
radioactivity. The first type of observation 
was made without consideration of the blood- 
brain barrier, which calls for the use of largo 
doses of radioactivity in order to get measur- 
able activities into the brain. The barrier, 
however, has little to do with the r a t e  of brain 
metabolism; it simply reduces the choice of 
precursors which the brain can draw upon. 
The researchers who made these experiments 
did not appreciate the need to consider time as 
a variable in discussing reaction rates. 
The second type of observation was made 
without examining the early time points so 
that the rapidly metabolizing fractions were 
missed. Unquestionably they point to the exis- 
tence of a fraction in brain which metabolizes 
very slowly and perhaps not at all. This 
might well be myelin or some lipid structure 
concerned with the preservation of memory 
(37). Our shorter term experinlents supple- 
ment the long term experiments and show that 
a portion of the brain lipid undergoes break- 
down even during the period of rapid deposi- 
tion. Indeed, the breakdown rates seem to be 
highest during the periods of most rapid 
synthesis or deposition. Lipid breakdown con- 
tinues well after the period of most rapid 
myelination. At the nlolnent there is no way 
to measure the relative amounts of the rapidly 
and slowly metabolizing fractions. 
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